Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

15.35
+1.359.64%
Post-market: 15.31-0.0400-0.26%18:33 EDT
Volume:364.31K
Turnover:5.35M
Market Cap:201.89M
PE:-2.56
High:15.49
Open:13.93
Low:13.60
Close:14.00
52wk High:16.00
52wk Low:3.39
Shares:13.15M
Float Shares:12.46M
Volume Ratio:1.62
T/O Rate:2.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0077
EPS(LYR):-7.9367
ROE:-90.25%
ROA:-32.01%
PB:1.93
PE(LYR):-1.93

Loading ...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Wuxi Biologics (Cayman) (OtherWXIBF) and Avalo Therapeutics (AVTX)

TIPRANKS
·
Oct 17

Avalo Therapeutics Inc publishes presentation on advancing IL1β therapies for hidradenitis suppurativa

Reuters
·
Oct 10

Avalo Therapeutics Inc. Files Initial Beneficial Ownership Statement for Chief Business Officer Boyd Taylor

Reuters
·
Oct 07

Avalo Therapeutics Files Initial Beneficial Ownership Statement for Director Kevin Robert Lind

Reuters
·
Oct 03

Avalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources

TIPRANKS
·
Oct 01

Avalo Therapeutics Announces New Inducement Compensation Plan Amid Leadership Expansion

Reuters
·
Oct 01

Press Release: Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources

Dow Jones
·
Oct 01

Oppenheimer Remains a Buy on Avalo Therapeutics (AVTX)

TIPRANKS
·
Sep 29

Avalo Therapeutics appoints Kevin Lind to board of directors

TIPRANKS
·
Sep 22

Press Release: Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

Dow Jones
·
Sep 22

Avalo Therapeutics, Inc.'s (NASDAQ:AVTX) institutional investors lost 11% over the past week but have profited from longer-term gains

Simply Wall St.
·
Sep 16

Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data

TIPRANKS
·
Sep 16

Avalo Therapeutics (AVTX) Gets a Buy from Oppenheimer

TIPRANKS
·
Sep 15

Avalo Therapeutics (AVTX) Receives a Buy from Piper Sandler

TIPRANKS
·
Sep 11

Avalo Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Sep 05

TD Cowen Initiates Avalo Therapeutics at Buy

MT Newswires Live
·
Sep 05

Cantor Fitzgerald Initiates Avalo Therapeutics at Overweight

MT Newswires Live
·
Aug 15

Avalo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

Avalo Therapeutics Inc expected to post a loss of $1.62 a share - Earnings Preview

Reuters
·
Aug 09

Avalo Therapeutics Q2 Operating Expenses USD 19.316 Million

THOMSON REUTERS
·
Aug 07